Hearing Loss Disease Portal


 
Switch to table view
Most Common: Hearing Loss (D034381), Deafness (D003638), Sensorineural HL (D006319), Waardenburg Syndrome, Usher Syndromes
Disease Browser
Parent Node:
expand
Muscle Spasticity (D009128)
Parent Node:
expand
Spinocerebellar Ataxias (D020754)
..Starting node
..expand
Spastic ataxia Charlevoix-Saguenay type (C536787)

       Child Nodes:



 Sister Nodes: 
..expandAnemia, sideroblastic spinocerebellar ataxia (C536358)
..expandAtaxia Telangiectasia (D001260) Child6
..expandChorioretinal Dystrophy, Spinocerebellar Ataxia, and Hypogonadotropic Hypogonadism (C565850)
..expandGemignani syndrome (C537678)
..expandMachado-Joseph Disease (D017827) Child1
..expandMITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE) (OMIM:271245)
..expandSpastic Ataxia (C564815)
..expandSpastic ataxia Charlevoix-Saguenay type (C536787)
..expandSpinocerebellar Ataxia 10 (C566874)
..expandSpinocerebellar Ataxia 11 (C565772)
..expandSpinocerebellar Ataxia 12 (C565790)
..expandSpinocerebellar Ataxia 15 (C564685)
..expandSpinocerebellar Ataxia 17 (C564616)
..expandSpinocerebellar ataxia 20 (C537199)
..expandSpinocerebellar ataxia 25 (C537202)
..expandSpinocerebellar ataxia 26 (C537203)
..expandSpinocerebellar ataxia 30 (C575214)
..expandSpinocerebellar Ataxia 31 (C566146)
..expandSpinocerebellar Ataxia And Plaque-Like Deposits (C566671)
..expandSpinocerebellar Ataxia with Dysmorphism (C564802)
..expandSpinocerebellar Ataxia with Epilepsy (C564395)
..expandSpinocerebellar Ataxia With Rigidity And Peripheral Neuropathy (C566669)
..expandSpinocerebellar Ataxia, Autosomal Recessive 7 (C563753)
..expandSpinocerebellar Ataxia, Autosomal Recessive 8 (C565188)
..expandSpinocerebellar Ataxia, Autosomal Recessive 9 (C567436)
..expandSpinocerebellar Ataxia, X-Linked 1 (C563134)
..expandSpinocerebellar Ataxia, X-Linked 5 (C567478)
   

Human Disease MESH is developed by UMLS.
Further data from MedGen, OMIM, CTD
Term ID:10356
Name:Spastic ataxia Charlevoix-Saguenay type
Definition:
Alternative IDs:OMIM:270550
ParentIDs:MESH:D009128|MESH:D020754
TreeNumbers:C05.651.512/C536787 |C10.228.140.252.190.530/C536787 |C10.228.140.252.700.700/C536787 |C10.228.854.787.875/C536787 |C10.574.500.825.700/C536787 |C10.597.350.090.500.530/C536787 |C10.597.613.550.550/C536787 |C16.320.400.780.875/C536787 |C23.888.592.608.550.550/C5
Synonyms:ARSACS |Autosomal recessive spastic ataxia of Charlevoix-Saguenay |Charlevoix-Saguenay spastic ataxia |SACS |SPASTIC ATAXIA 6, AUTOSOMAL RECESSIVE |Spastic Ataxia, Charlevoix-Saguenay Type |Spastic ataxia of Charlevoix-Saguenay |SPAX6
Slim Mappings:Genetic disease (inborn)|Musculoskeletal disease|Nervous system disease|Signs and symptoms
Reference: MedGen: C536787
MeSH: C536787
OMIM: 270550;

Genes: SACS;
Phenotypes
1 HP:0000007Autosomal recessive inheritance
2 HP:0003593Infantile onset
3 HP:0003438Absent Achilles reflex
4 HP:0003487Babinski sign
5 HP:0006855Cerebellar vermis atrophy
6 HP:0003431Decreased motor nerve conduction velocity
7 HP:0003387Decreased number of large peripheral myelinated nerve fibers
8 HP:0003448Decreased sensory nerve conduction velocity
9 HP:0003693Distal amyotrophy
10 HP:0002460Distal muscle weakness
11 HP:0002936Distal sensory impairment
12 HP:0001260Dysarthria
13 HP:0001310Dysmetria
14 HP:0002527Falls
15 HP:0001765Hammertoe
16 HP:0007922Hypermyelinated retinal nerve fibers
17 HP:0001347Hyperreflexia
18 HP:0007772Impaired smooth pursuit
19 HP:0002166Impaired vibration sensation in the lower limbs
20 HP:0001249Intellectual disability
21 HP:0007001Loss of Purkinje cells in the cerebellar vermis
22 HP:0000639Nystagmus
23 HP:0001761Pes cavus
24 HP:0007240Progressive gait ataxia
25 HP:0007221Progressive truncal ataxia
26 HP:0002168Scanning speech
27 HP:0002497Spastic ataxia
28 HP:0001257Spasticity
29 HP:0006150Swan neck-like deformities of the fingers
30 HP:0000012Urinary urgency
Disease Causing ClinVar Variants
Variation_NameGeneIDGeneSymbolClinicalSignificancedbSNPRCVaccessionTestedInGTRPhenotypeIDsChromosomeStartStopHGVS_cHGVS_pHGVS_gOtherIDsDisease_ClinVarDisease_hgmd
NM_014363.5(SACS):c.13527dupA (p.Glu4510Argfs)26278SACSPathogenic797045936RCV000194514; NMedGen:C1849140,OMIM:270550,ORPHA:98132390448823904488NM_014363.5:c.13527dupANP_055178.3:p.Glu4510ArgfsNC_000013.10:g.23904488dupT-C1849140 270550 Spastic ataxia Charlevoix-Saguenay type
NM_014363.5(SACS):c.12973C>T (p.Arg4325Ter)26278SACSLikely pathogenic762947018RCV000169272; NMedGen:C1849140,OMIM:270550,ORPHA:98132390504223905042NM_014363.5:c.12973C>TNP_055178.3:p.Arg4325TerNC_000013.10:g.23905042G>A-C1849140 270550 Spastic ataxia Charlevoix-Saguenay type
NM_014363.5(SACS):c.12851_12854delAGAG (p.Glu4284Alafs)26278SACSLikely pathogenic786204628RCV000169401; NMedGen:C1849140,OMIM:270550,ORPHA:98132390516123905164NM_014363.5:c.12851_12854delAGAGNP_055178.3:p.Glu4284AlafsNC_000013.10:g.23905161_23905164delCTCT-C1849140 270550 Spastic ataxia Charlevoix-Saguenay type
NM_014363.5(SACS):c.12232C>T (p.Arg4078Ter)26278SACSLikely pathogenic141315518RCV000169220; NMedGen:C1849140,OMIM:270550,ORPHA:98132390578323905783NM_014363.5:c.12232C>TNP_055178.3:p.Arg4078TerNC_000013.10:g.23905783G>A-C1849140 270550 Spastic ataxia Charlevoix-Saguenay type
NM_014363.5(SACS):c.12220G>C (p.Ala4074Pro)26278SACSPathogenic137853016RCV000005849; NMedGen:C1849140,OMIM:270550,ORPHA:98132390579523905795NM_014363.5:c.12220G>CNP_055178.3:p.Ala4074ProNC_000013.10:g.23905795C>GOMIM Allelic Variant:604490.0003C1849140 270550 Spastic ataxia Charlevoix-Saguenay type
NM_014363.5(SACS):c.12160C>T (p.Gln4054Ter)26278SACSPathogenic281865120RCV000032008; NMedGen:C1849140,OMIM:270550,ORPHA:98132390585523905855NM_014363.5:c.12160C>TNP_055178.3:p.Gln4054TerNC_000013.10:g.23905855G>A-C1849140 270550 Spastic ataxia Charlevoix-Saguenay type
NM_014363.5(SACS):c.11624G>A (p.Arg3875His)26278SACSLikely pathogenic863224916RCV000197883; NMedGen:C1849140,OMIM:270550,ORPHA:98132390639123906391NM_014363.5:c.11624G>ANP_055178.3:p.Arg3875HisNC_000013.10:g.23906391C>T-C1849140 270550 Spastic ataxia Charlevoix-Saguenay type
NM_014363.5(SACS):c.10907G>A (p.Arg3636Gln)26278SACSPathogenic281865119RCV000032007; NMedGen:C1849140,OMIM:270550,ORPHA:98132390710823907108NM_014363.5:c.10907G>ANP_055178.3:p.Arg3636GlnNC_000013.10:g.23907108C>T-C1849140 270550 Spastic ataxia Charlevoix-Saguenay type
NM_014363.5(SACS):c.10906C>T (p.Arg3636Ter)26278SACSPathogenic780247476RCV000192438; NMedGen:C1849140,OMIM:270550,ORPHA:98132390710923907109NM_014363.5:c.10906C>TNP_055178.3:p.Arg3636TerNC_000013.10:g.23907109G>A-C1849140 270550 Spastic ataxia Charlevoix-Saguenay type
NM_014363.5(SACS):c.10466_10467delCT (p.Ser3489Leufs)26278SACSLikely pathogenic786204416RCV000168999; NMedGen:C1849140,OMIM:270550,ORPHA:98132390754823907549NM_014363.5:c.10466_10467delCTNP_055178.3:p.Ser3489LeufsNC_000013.10:g.23907548_23907549delAG-C1849140 270550 Spastic ataxia Charlevoix-Saguenay type
NM_014363.5(SACS):c.9742T>C (p.Trp3248Arg)26278SACSPathogenic137853018RCV000005854; NMedGen:C1849140,OMIM:270550,ORPHA:98132390827323908273NM_014363.5:c.9742T>CNP_055178.3:p.Trp3248ArgNC_000013.10:g.23908273A>GOMIM Allelic Variant:604490.0008C1849140 270550 Spastic ataxia Charlevoix-Saguenay type
NM_014363.5(SACS):c.8848_8849dupCA (p.Val2951Metfs)26278SACSLikely pathogenic797044608RCV000194102; NMedGen:C1849140,OMIM:270550,ORPHA:98132390916623909167NM_014363.5:c.8848_8849dupCANP_055178.3:p.Val2951MetfsNC_000013.10:g.23909166_23909167dupTG-C1849140 270550 Spastic ataxia Charlevoix-Saguenay type
NM_014363.5(SACS):c.8844delT (p.Ile2949Phefs)26278SACSPathogenic281865117RCV000005847; NMedGen:C1849140,OMIM:270550,ORPHA:98132390917123909171NM_014363.5:c.8844delTNP_055178.3:p.Ile2949PhefsNC_000013.10:g.23909171delAGeneReviews:NBK1255,OMIM Allelic Variant:604490.0001C1849140 270550 Spastic ataxia Charlevoix-Saguenay type
NM_014363.5(SACS):c.8542_8543delTT (p.Phe2848Profs)26278SACSPathogenic-1RCV000218042; NMedGen:C1849140,OMIM:270550,ORPHA:98132390947223909473NM_014363.5:c.8542_8543delTTNP_055178.3:p.Phe2848Profs-C1849140 270550 Spastic ataxia Charlevoix-Saguenay type
NM_014363.5(SACS):c.8393C>A (p.Pro2798Gln)26278SACSLikely pathogenic140551762RCV000194652; NMedGen:C1849140,OMIM:270550,ORPHA:98132390962223909622NM_014363.5:c.8393C>ANP_055178.3:p.Pro2798GlnNC_000013.10:g.23909622G>T-C1849140 270550 Spastic ataxia Charlevoix-Saguenay type
NM_014363.5(SACS):c.7641dupA (p.Glu2548Argfs)26278SACSPathogenic-1RCV000214078; NMedGen:C1849140,OMIM:270550,ORPHA:98132391037423910374NM_014363.5:c.7641dupANP_055178.3:p.Glu2548Argfs-C1849140 270550 Spastic ataxia Charlevoix-Saguenay type
NM_014363.5(SACS):c.7504C>T (p.Arg2502Ter)26278SACSPathogenic281865118RCV000005848; NMedGen:C1849140,OMIM:270550,ORPHA:98132391051123910511NM_014363.5:c.7504C>TNP_055178.3:p.Arg2502TerNC_000013.10:g.23910511G>AOMIM Allelic Variant:604490.0002C1849140 270550 Spastic ataxia Charlevoix-Saguenay type
NM_014363.5(SACS):c.7276C>T (p.Arg2426Ter)26278SACSLikely pathogenic786204750RCV000169603; RCV000197883; NMedGen:C1849140,OMIM:270550,ORPHA:98132391073923910739NM_014363.5:c.7276C>TNP_055178.3:p.Arg2426TerNC_000013.10:g.23910739G>A-C1849140 270550 Spastic ataxia Charlevoix-Saguenay type
NM_014363.5(SACS):c.7276C>T (p.Arg2426Ter)26278SACSLikely pathogenic786204750RCV000169603; RCV000197883; NMedGen:C1849140,OMIM:270550,ORPHA:98132391073923910739NM_014363.5:c.7276C>TNP_055178.3:p.Arg2426TerNC_000013.10:g.23910739G>A-C1849140 270550 Spastic ataxia Charlevoix-Saguenay type
NM_014363.5(SACS):c.5836T>C (p.Trp1946Arg)26278SACSPathogenic137853017RCV000005852; NMedGen:C1849140,OMIM:270550,ORPHA:98132391217923912179NM_014363.5:c.5836T>CNP_055178.3:p.Trp1946ArgNC_000013.10:g.23912179A>GOMIM Allelic Variant:604490.0006C1849140 270550 Spastic ataxia Charlevoix-Saguenay type
NM_014363.5(SACS):c.4033dupC (p.Gln1345Profs)26278SACSPathogenic606231163RCV000005853; NMedGen:C1849140,OMIM:270550,ORPHA:98132391398223913982NM_014363.5:c.4033dupCNP_055178.3:p.Gln1345ProfsNC_000013.10:g.23913982dupGOMIM Allelic Variant:604490.0007C1849140 270550 Spastic ataxia Charlevoix-Saguenay type
NM_014363.5(SACS):c.3589T>C (p.Ser1197Pro)26278SACSLikely pathogenic727503785RCV000157061; NMedGen:C1849140,OMIM:270550,ORPHA:98132391442623914426NM_014363.5:c.3589T>CNP_055178.3:p.Ser1197ProNC_000013.10:g.23914426A>G-C1849140 270550 Spastic ataxia Charlevoix-Saguenay type
NM_014363.5(SACS):c.3328dupA (p.Ile1110Asnfs)26278SACSLikely pathogenic773840580RCV000169583; NMedGen:C1849140,OMIM:270550,ORPHA:98132391468723914687NM_014363.5:c.3328dupANP_055178.3:p.Ile1110AsnfsNC_000013.10:g.23914687dupT-C1849140 270550 Spastic ataxia Charlevoix-Saguenay type
NM_014363.5(SACS):c.3161T>C (p.Phe1054Ser)26278SACSPathogenic137853019RCV000005855; NMedGen:C1849140,OMIM:270550,ORPHA:98132391485423914854NM_014363.5:c.3161T>CNP_055178.3:p.Phe1054SerNC_000013.10:g.23914854A>GOMIM Allelic Variant:604490.0009C1849140 270550 Spastic ataxia Charlevoix-Saguenay type
NM_014363.5(SACS):c.2439_2440delAT (p.Val815Glyfs)26278SACSLikely pathogenic775059063RCV000169208; NMedGen:C1849140,OMIM:270550,ORPHA:98132391557523915576NM_014363.5:c.2439_2440delATNP_055178.3:p.Val815GlyfsNC_000013.10:g.23915575_23915576delAT-C1849140 270550 Spastic ataxia Charlevoix-Saguenay type
NM_014363.5(SACS):c.1919_1920delAC (p.His640Profs)26278SACSPathogenic797045937RCV000192515; NMedGen:C1849140,OMIM:270550,ORPHA:98132392883123928832NM_014363.5:c.1919_1920delACNP_055178.3:p.His640ProfsNC_000013.10:g.23928831_23928832delGT-C1849140 270550 Spastic ataxia Charlevoix-Saguenay type